Content about Blood

March 17, 2014

Bristol-Myers Squibb Co. and Pfizer announced that the Food and Drug Administration approved a supplemental new drug application for Eliquis (apixaban). The drug is a preventive treatment for deep vein thrombosis, which can lead to pulmonary embolism for patients who have had hip or knee replacement surgery.

PRINCETON, N.J. and NEW YORK — Bristol-Myers Squibb Co. and Pfizer announced that the Food and Drug Administration approved a supplemental new drug application for Eliquis (apixaban). The drug is a preventive treatment for deep vein thrombosis, which can lead to pulmonary embolism for patients who have had hip or knee replacement surgery.  

April 30, 2013

The Food and Drug Administration has approved a drug that reverses the effects of anticoagulant drugs in patients who have suffered acute major bleeding, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved a drug that reverses the effects of anticoagulant drugs in patients who have suffered acute major bleeding, the agency said.

The FDA announced the approval of CSL Behring's Kcentra (prothrombin complex concentrate [human]) for the urgent reversal of vitamin K antagonist, or VKA drugs such as warfarin.

January 17, 2013

The Food and Drug Administraiton has approved a drug for replacing clotting proteins in the blood for conditions in which patients have too little of them.

SILVER SPRING, Md. — The Food and Drug Administraiton has approved a treatment for replacing clotting proteins in the blood for conditions in which patients have too little of them.

The FDA announced the approval of Octapharma's Octaplas, a sterile, frozen solution of pooled human plasma from multiple donors that has been treated with a solvent detergent process.

January 8, 2013

iHealth Labs on Monday unveiled two new additions to its suite of devices — the iHealth Wireless Smart Gluco-Monitoring System and iHealth Pulse Oximeter — at the 2013 Consumer Electronics Show in Las Vegas.

LAS VEGAS — iHealth Labs on Monday unveiled two new additions to its suite of devices — the iHealth Wireless Smart Gluco-Monitoring System and iHealth Pulse Oximeter — at the 2013 Consumer Electronics Show here. 

December 12, 2012

Xtreme Lashes is aiming to revolutionize the way lash extension wearers manage their daily anti-aging eye care regimen with its new Total Eye Repair Serum.

SPRING, Texas — Xtreme Lashes is aiming to revolutionize the way lash extension wearers manage their daily anti-aging eye care regimen with its new Total Eye Repair Serum. The oil-free serum is designed to target multiple signs of aging without interfering with the look and lifespan of lash extensions.

December 5, 2012

Patients once considered "aspirin resistant" may not be resistant to aspirin after all, according to a study published online by Circulation, the journal of the American Heart Association. Rather, the protective coating around the aspirin to prevent stomach issues may be delaying the absorption of aspirin, leading clinicians to believe that patients are aspirin resistant.

PHILADELPHIA — Patients once considered "aspirin resistant" may not be resistant to aspirin after all, according to a study published online by Circulation, the journal of the American Heart Association. Rather, the protective coating around the aspirin to prevent stomach issues may be delaying the absorption of aspirin, leading clinicians to believe that patients are aspirin resistant. 

November 19, 2012

The Food and Drug Administration has approved a drug for a condition that can complicate treatment for hepatitis C.

LONDON — The Food and Drug Administration has approved a drug for a condition that can complicate treatment for hepatitis C.

GlaxoSmithKline said Monday that the FDA had approved Promacta (eltrombopag) for treating low blood-platelet counts, also known as thrombocytopenia, to allow patients with hepatitis C to undergo and maintain interferon-based therapy. The drug already had FDA approval to treat chronic immune thrombocytopenia. 

November 5, 2012

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating internal blood clots, the company said.

RARITAN, N.J. — The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating internal blood clots, the company said.

J&J subsidiary Janssen Pharmaceuticals announced the approval of Xarelto (rivaroxaban) for treating deep-vein thrombosis and pulmonary embolism and to reduce the risk of recurrence of the clotting conditions after initial treatment.

The company said Xarelto was the first oral anticoagulant approved to treat DVT and PE without the need for injections or routine blood-monitoring.

January 12, 2012

Drug maker Octapharma USA has appointed David Holliday as VP commercial development, the company said.

HOBOKEN, N.J. — Drug maker Octapharma USA has appointed David Holliday as VP commercial development, the company said.

December 7, 2011

Prescribers, patients and specialty care centers no longer will be required to enroll in safety monitoring programs for two drugs used to treat low platelet counts, following changes to their risk evaluation and mitigation strategies.

SILVER SPRING, Md. — Prescribers, patients and specialty care centers no longer will be required to enroll in safety monitoring programs for two drugs used to treat low platelet counts, following changes to their risk evaluation and mitigation strategies.

August 22, 2011

A new drug made by AstraZeneca is available in pharmacies following its regulatory approval in July, the company said Monday.

WILMINGTON, Del. — A new drug made by AstraZeneca is available in pharmacies following its regulatory approval in July, the company said Monday.

AstraZeneca announced the availability of the anti-platelet drug Brilinta (ticagrelor) for reducing the rate of thrombotic cardiovascular events in patients with acute coronary syndrome.

The Food and Drug Administration approved Brilinta on July 20. AstraZeneca said the drug has been shown to reduce the rates of cardiovascular death, heart attacks and stroke, compared with other drugs on the market.

January 5, 2011

A designer and manufacturer of digital personal healthcare products has launched a blood-pressure monitoring system for the Apple iPhone, iPod Touch and iPad.

LAS VEGAS — A designer and manufacturer of digital personal healthcare products has launched a blood-pressure monitoring system for the Apple iPhone, iPod Touch and iPad.

IHealth Lab's iHealth blood-pressure monitoring system lets users measure and track their blood pressure and heart rate.

December 6, 2010

A drug made by Amgen maintained blood platelet counts in patients with an autoimmune bleeding disorder, according to results of a five-year study released Sunday.

ORLANDO, Fla. — A drug made by Amgen maintained blood platelet counts in patients with an autoimmune bleeding disorder, according to results of a five-year study released Sunday.

August 2, 2010

The Food and Drug Administration has given orphan drug designation to a treatment for an...

June 27, 2010

Bayer HealthCare Pharmaceuticals has launched a free mobile application for patients with hemophilia, the drug...

May 12, 2010

A drug for treating the bleeding disorder von Willebrand disease has become available, manufacturer Octapharma...

March 11, 2010

CVS had this citrus-flavored Bayer aspirin quick release crystals clip-stripped within adult dentures. And while...

CVS had this citrus-flavored Bayer aspirin quick release crystals clip-stripped within adult dentures. And while this product isn’t the 81 mg of aspirin recommended for daily consumption to prevent a second heart attack (it contains 850 mg in each powder pouch), there is still a very strong need for this kind of easily stored/quickly administered aspirin product for seniors.

September 10, 2007

The Body Shop founder Anita Roddick, who used her cosmetics company to help communicate human...